文献速递心脑血管急症重症综合管理与镇静镇痛

细胞外冷诱导RNA结合蛋白预测心脏骤停后患者严重程度与预后的价值:一项初步观察性研究

The Value of Extracellular Cold-Inducible RNA-Binding Protein (eCIRP) in Predicting the Severity and Prognosis of Patients After Cardiac Arrest: A Preliminary Observational Study.
PubMed 文献 · Shock · 2021-01-01
一句话结论ROSC后第3天血清eCIRP对28天死亡和神经预后预测价值最高,AUC分别为0.862和0.807,可作为潜在生物标志物。

该初步观察性研究纳入73例ROSC患者(28天非存活组48例、存活组25例)及25例健康对照,在ROSC后第1、3、7天检测血清eCIRP、PCT、TNF-α、IL-6、HMGB1、NSE、S100β,并计算SOFA和APACHE II评分。结果显示ROSC后第一周eCIRP等指标显著升高,eCIRP与IL-6、TNF-α、乳酸、NSE、S100β、CPR时间、SOFA、APACHE II及HMGB1正相关。ROSC后第1、3、7天eCIRP均可预测28天死亡和神经预后,其中第3天AUC最大,分别为0.862(95%CI 0.741-0.941)和0.807(95%CI 0.630-0.981)。提示eCIRP可能作为ROSC后严重程度和预后评估的潜在生物标志物。

要点

  • ROSC后第3天血清eCIRP预测28天死亡的AUC为0.862(95%CI 0.741-0.941),为各时间点中最大。
  • ROSC后第3天血清eCIRP预测神经预后的AUC为0.807(95%CI 0.630-0.981),为各时间点中最大。
  • eCIRP与IL-6、TNF-α、乳酸、NSE、S100β、CPR时间、SOFA、APACHE II及HMGB1呈正相关,反映全身炎症反应和严重程度。
  • ROSC后第一周eCIRP、IL-6、TNF-α、PCT、HMGB1、NSE、S100β均显著升高。
  • 该研究为初步观察性研究,样本量小(73例ROSC患者),eCIRP的预测阈值和临床决策价值尚需前瞻性验证。

适用人群与场景

  • 心脏骤停后恢复自主循环(ROSC)的患者,根据28天生存分为非存活组(n=48)和存活组(n=25);健康志愿者(n=25)作为对照。
  • 原文未提及纳入/排除标准的具体条目、急诊或ICU场景、病情阶段。

诊断标准与关键阈值

  • 原文未提及eCIRP的诊断标准、评分界值或启动/停止阈值。
  • 研究中使用SOFA评分和APACHE II评分评估严重程度,但原文未给出具体界值。
  • 神经预后采用ROSC后第28天脑功能分类(CPC)评分记录,原文未给出CPC界值定义。

处置流程与药物剂量

  • 原文未提及基于eCIRP的具体处置流程或药物剂量。

红旗征与不能漏的情况

  • 原文未提及红旗征或需要立刻处理的情况。

研究设计与关键结果

  • 研究类型:初步观察性研究;样本量:73例ROSC患者(非存活48例、存活25例)及25例健康对照;单中心或多中心原文未提及。
  • 干预与对照:无干预,比较ROSC患者与健康对照,以及非存活组与存活组。
  • 主要终点结果:ROSC后第3天血清eCIRP预测28天死亡的AUC为0.862(95%CI 0.741-0.941),预测神经预后的AUC为0.807(95%CI 0.630-0.981)。
  • 关键次要终点:ROSC后第一周eCIRP、IL-6、TNF-α、PCT、HMGB1、NSE、S100β显著升高;eCIRP与IL-6、TNF-α、乳酸、NSE、S100β、CPR时间、SOFA、APACHE II及HMGB1正相关。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:初步观察性研究(非RCT、非系统评价、非指南)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:样本量小(73例ROSC患者),为初步观察性研究,原文未提及单中心/多中心、回顾性或前瞻性设计,eCIRP预测阈值未建立,需前瞻性验证。

对床旁实践的改变

  • 该研究提示ROSC后第3天血清eCIRP可能作为预测28天死亡和神经预后的潜在生物标志物,但原文未提供决策阈值,尚不能改变急诊/ICU现有做法。
  • 适用人群为ROSC后患者;不适用人群原文未提及。
  • 常见陷阱:eCIRP为研究性指标,不能替代SOFA、APACHE II等现有评估;AUC来自小样本初步研究,不能据此设定临床决策阈值。

指南或共识出处

  • 原文未提及指南或共识名称;文献来源为Shock期刊。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Extracellular cold-inducible RNA-binding protein (eCIRP) acting as a novel damage-associated molecular pattern molecule promotes systemic inflammatory responses, including neuroinflammation in cerebral ischemia. We aimed to observe the changes of serum eCIRP and evaluate whether the increased serum eCIRP was associated with the severity and prognosis in patients with restoration of spontaneous circulation (ROSC).

METHODS: A total of 73 patients after ROSC were divided into non-survivor (n = 48) and survivor (n = 25) groups based on 28-day survival. Healthy volunteers (n = 25) were enrolled as controls. Serum eCIRP, procalcitonin (PCT), the pro-inflammatory mediators tumor necrosis factor (TNF)-α, interleukin-6 (IL)-6 and high mobility group protein (HMGB1), the neurological damage biomarkers neuron-specific enolase (NSE), and soluble protein 100β (S100β) were measured on days 1, 3, and 7 after ROSC. Clinical data and laboratory findings were collected, and the Sequential Organ Failure Assessment (SOFA) score and Acute Physiology and Chronic Health Evaluation (APACHE II) were calculated concurrently. Cerebral performance category scores on day 28 after ROSC were recorded.

RESULTS: Serum eCIRP, IL-6, TNF-α, PCT, and HMGB1, NSE and S100β were significantly increased within the first week after ROSC. The increased levels of eCIRP were positively correlated with IL-6, TNF-α, lactate, NSE, S100β, CPR time, SOFA score, APACHE II score, and HMGB1 after ROSC. Serum eCIRP on days 1, 3, and 7 after ROSC could predict 28-day mortality and neurological prognosis. Serum eCIRP on day 3 after ROSC had a biggest AUC [0.862 (95% CI: 0.741-0.941)] for 28-day mortality and a biggest AUC [0.807 (95% CI: 0.630-0.981)] for neurological prognosis.

CONCLUSIONS: Systemic inflammatory response with increased serum eCIRP occurred in patients after ROSC. Increased eCIRP level was positively correlated with the aggravation of systemic inflammatory response and the severity after ROSC. Serum eCIRP serves as a potential predictor for 28-day mortality and poor neurological prognosis after ROSC.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Li RF, Guan XL, et al. The Value of Extracellular Cold-Inducible RNA-Binding Protein (eCIRP) in Predicting the Severity and Prognosis of Patients After Cardiac Arrest: A Preliminary Observational Study. Shock. 2021. PMID: 34276038. doi:10.1097/SHK.0000000000001702

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。